ALLENA PHARMACEUTICALS BOSTON

allena-pharmaceuticals-boston-logo

Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to create innovative treatments for patients with rare and severe metabolic and kidney disorders. One of their notable achievements includes the positive topline results from the URIROX-1 Trial and from Study 206, which are significant contributions to the medical field.

#SimilarOrganizations #People #Website #More

ALLENA PHARMACEUTICALS BOSTON

Social Links:

Industry:
Biotechnology

Founded:
2011-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.allenapharma.com

Status:
Active


Similar Organizations

adicet-bio-logo

Adicet Bio

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

adnovate-clinical-logo

Adnovate Clinical

Adnovate Clinical is a biotechnology industry.

alphathera-logo

AlphaThera

AlphaThera is a biotechnology industry.

functional-biosciences-logo

Functional Biosciences

Functional Biosciences is a biotechnology industry firm.

landmark-bio-logo

Landmark Bio

Landmark Bio is a biotechnology industry.

rage-biotech-logo

RAGE Biotech

RAGE Biotech is a biotechnology industry.


Current Advisors List

alexey-margolin_image

Alexey Margolin Chairman Of The Board @ Allena Pharmaceuticals Boston
Board_member
2019-02-01

Founder


alexey-margolin_image

Alexey Margolin

Official Site Inspections

http://www.allenapharma.com

Unable to get host informations!!!

Loading ...

More informations about "Allena Pharmaceuticals Boston"

Main Page - Alenapharma

As a member of the Televida Groupโ€”an organization dedicated to advancing Healthtech and Mobile Techโ€”Alena Pharma is uniquely positioned to drive progress in diabetes and โ€ฆSee details»

Allena Pharmaceuticals, Inc. - LinkedIn

Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney ...See details»

Allena Pharmaceuticals 2025 Company Profile: โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Allena Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

Allena Pharmaceuticals, Inc. - AnnualReports.com

Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney โ€ฆSee details»

Allena Pharmaceuticals - VentureRadar

"Allena Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan โ€ฆSee details»

Allena Pharmaceuticals, Inc. Company Profile | Sudbury, MA ...

Find company research, competitor information, contact details & financial data for Allena Pharmaceuticals, Inc. of Sudbury, MA. Get the latest business insights from Dun & Bradstreet.See details»

Allena Pharmaceuticals - The Org

Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic โ€ฆSee details»

Allena Pharmaceuticals Inc (ALNAQ) Profile - The Globe and Mail

See the company profile for Allena Pharmaceuticals Inc (ALNAQ) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Allena Pharmaceuticals CEO and Key Executive Team | Craft.co

Allena Pharmaceuticals's Vice President of Technical Operations is Hugh Wight. Other executives include Louis Brenner, President and Chief Executive Office; Edward Wholihan, CFO and 3 โ€ฆSee details»

Allena - Company Profile - Tracxn

Jan 31, 2025 Allena is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic โ€ฆSee details»

Allena Pharmaceuticals - Craft

Nov 8, 2022 Allena Pharmaceuticals is a company that develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. It is focused on treating โ€ฆSee details»

Allena Pharmaceuticals Boston - Crunchbase Company Profile

Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to โ€ฆSee details»

Allena Pharmaceuticals' CEO and Executive Team - The Org

Allena Pharmaceuticals' CEO and Executive Team includes Louis Brenner and 5 others.See details»

Allena Pharmaceuticals Company Profile | Management and

Find contact information for Allena Pharmaceuticals. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Allena Pharmaceuticals's email format.See details»

Allena Pharmaceuticals - Bessemer Venture Partners

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.See details»

Overview, News & Similar companies - ZoomInfo.com

Jul 12, 2022 View Allena Pharmaceuticals (www.allenapharma.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

Allena Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Nov 2, 2017 About Allena Pharmaceuticals Allena Pharmaceuticals (OTCMKTS: ALNAQ) operates as a pharmaceutical company. It develops oral enzyme therapeutic for the treatment โ€ฆSee details»

Allena Pharmaceuticals Provides Clinical and Corporate

Jan 4, 2022 Allena Pharmaceuticals Provides Clinical and Corporate Update January 04, 2022 05:00 ET | Source: Allena Pharmaceuticals, Inc.See details»

Allena Pharmaceuticals, Inc. (Allena Pharmaceuticals, Inc.) - ่ฏ็‰ฉ็ฎก โ€ฆ

The purpose of this Phase IIa study is to evaluate the safety, tolerability and pharmacodynamics of ALLN-346 in subjects with hyperuricemia and gout, and with mild to moderate chronic โ€ฆSee details»

Allena Pharmaceuticals Announces $28 Million Registered

Jul 14, 2021 Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules July 13, 2021 23:43 ET | Source: Allena Pharmaceuticals, โ€ฆSee details»

linkstock.net © 2022. All rights reserved